<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Res Cardiovasc Med</journal-id><journal-id journal-id-type="iso-abbrev">Res Cardiovasc Med</journal-id><journal-id journal-id-type="doi">10.5812/cardiovascmed</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Research in Cardiovascular Medicine</journal-title></journal-title-group><issn pub-type="ppub">2251-9572</issn><issn pub-type="epub">2251-9580</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25478518</article-id><article-id pub-id-type="pmc">4253786</article-id><article-id pub-id-type="doi">10.5812/cardiovascmed.10719</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Deep Sedation In Patients Undergoing Atrioventricular Nodal Reentry Tachycardia Ablation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fazelifar</surname><given-names>Amirfarjam</given-names></name><xref ref-type="aff" rid="aff21792">1</xref><xref ref-type="corresp" rid="cor21793">*</xref></contrib><contrib contrib-type="author"><name><surname>Eskandari</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="aff21794">2</xref></contrib><contrib contrib-type="author"><name><surname>Hashemi</surname><given-names>Mohammadjafar</given-names></name><xref ref-type="aff" rid="aff21794">2</xref></contrib><contrib contrib-type="author"><name><surname>Alavi</surname><given-names>Mostafa</given-names></name><xref ref-type="aff" rid="aff21794">2</xref></contrib><contrib contrib-type="author"><name><surname>Totounchi</surname><given-names>Mohammadzia</given-names></name><xref ref-type="aff" rid="aff21794">2</xref></contrib><contrib contrib-type="author"><name><surname>Forghanian</surname><given-names>Azam</given-names></name><xref ref-type="aff" rid="aff21795">3</xref></contrib><contrib contrib-type="author"><name><surname>Zeighami</surname><given-names>Mahboubeh</given-names></name><xref ref-type="aff" rid="aff21795">3</xref></contrib><contrib contrib-type="author"><name><surname>Emkanjoo</surname><given-names>Zahra</given-names></name><xref ref-type="aff" rid="aff21792">1</xref></contrib><contrib contrib-type="author"><name><surname>Haghjoo</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff21792">1</xref></contrib></contrib-group><aff id="aff21792"><label>1</label>Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff21794"><label>2</label>Department of Anesthesiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff21795"><label>3</label>Electrophysiology Laboratory, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran</aff><author-notes><corresp id="cor21793"><label>*</label>Corresponding author: Amirfarjam Fazelifar, Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Vali-Asr Ave, Niayesh Blvd, Tehran, IR Iran. Tel: +98-2123922931, Fax: +98-2122048174, E-mail: <email>fazelifar@rhc.ac.ir</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>10</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2013</year></pub-date><volume>2</volume><issue>4</issue><fpage>176</fpage><lpage>179</lpage><history><date date-type="received"><day>13</day><month>2</month><year>2013</year></date><date date-type="rev-recd"><day>06</day><month>7</month><year>2013</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran; Published by Kowsar Corp.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>General anesthesia and deep sedation can be used during cardiac EPS to relief pain and provide comfort and immobility, but many electrophysiologists avoid sedation for better arrhythmia induction.</p></sec><sec><title>Objective:</title><p>To determine anesthesia effects in ablation procedures in adults, we used intravenous anesthetic agents in patients who underwent slow pathway ablation.</p></sec><sec><title>Patients and Methods:</title><p>One hundred patients who were to undergo radiofrequency catheter ablation were randomly assigned to with and without intravenous anesthesia groups. All patients had palpitation with a documented electrocardiography (ECG) compatible with atrio-ventricular nodal reentrant tachycardia (AVNRT). We used propofol, fentanyl and midazolam for intravenous sedation. Electrophysiological parameters were checked for the two groups and compared before and after the ablation.</p></sec><sec><title>Results:</title><p>Electrophysiological parameters were not significantly different in the two groups. In the anesthetic group, patients were more satisfied with the procedure (P value &#x0003c; 0. 001).</p></sec><sec><title>Conclusions:</title><p>Intravenous anesthesia could be done safely in patients who underwent electrophysiological procedures. It had no effect on arrhythmia induction or slow pathway ablation in patients with documented AVNRT.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Atrio-Ventricular Nodal Reentrant Tachycardia</kwd><kwd>Deep Sedation</kwd><kwd>Ablation Techniques Introduction</kwd></kwd-group></article-meta></front><body><sec id="sec27137"><title>1. Background</title><p>Electrophysiological testing (EPS) and ablation are effective invasive procedures in symptomatic arrhythmic patients. Atrio-ventricular node reentrant tachycardia (AVNRT) is the most frequent arrhythmia in these patients. General anesthesia and deep sedation can be used during cardiac EPS to relief pain and provide comfort and immobility, but many electrophysiologists avoid sedation for better arrhythmia induction. The effect of anesthetic drugs on the conduction system are controversial and some reports have revealed associations between anesthetic drugs and supraventricular arrhythmia termination while others have demonstrate no effect from propofol and/or isoflurane on atrial/ventricular tissue or atrioventricular node function (<xref rid="A10719R1" ref-type="bibr">1</xref>, <xref rid="A10719R2" ref-type="bibr">2</xref>). However, successful management of anesthesia in patients undergoing radiofrequency catheter ablation (RFCA) requires that the pathologic tachycardia remains inducible.</p></sec><sec id="sec27138"><title>2. Objective</title><p>In this study we tried to evaluate the effect of anesthesia on AVNRT management.</p></sec><sec id="sec27141"><title>3. Patients and Methods</title><p>A total of 100 consecutive patients were included during January to December 2011. All patients underwent radiofrequency catheter ablation (RFCA) for symptomatic arrhythmia compatible with AVNRT and were informed about the details of the procedure and the anesthesia protocol, if they were included in the anesthetic group. Written informed consent was obtained from all patients. All antiarrhythmic drugs had been discontinued for at least five half-lives before the procedure. All patients were categorized randomly into two groups of with (Group A) and without (Group B) anesthesia. Patients with double arrhythmias or other types of arrhythmias were excluded from the study.</p><sec id="sec27139"><title>3.1. Intravenous Anesthesia</title><p>An anesthesiologist was responsible for anesthesia induction and at least one anesthesia nurse was dedicated for vital signs monitoring (BP and pulse oximetry) and propofol administration. Anesthesia induction was performed with fentanyl (1 &#x000b5;/kg), midazolam (0.03 mg/kg) and propofol (200&#x000b5;/kg/min). When the patient could no longer be aroused, the infusion rate was decreased and adjusted according to the patient&#x02019;s condition. An oral airway was used for airway protection. A nasal canola was used with an O<sub>2</sub> flow of 2 L/min. Cuff blood pressure monitoring and pulse oximetry were used for continuous vital signs monitoring. We did not use pre-medications such as atropin because of electrophysiological effects. All patients recovered within 30 minutes after anesthesia protocol termination. </p></sec><sec id="sec27140"><title>3.2. Electrophysiological Study</title><p>In the anesthetic group (Group A) catheter placement was performed after anesthesia induction and there was no response to the painful stimulation. In the non-anesthetic group (Group B), catheter placement was done after local anesthesia. All patients received four mapping catheters in the right atrium, right ventricular apex, His bundle region and coronary sinus. Intracardiac electrogram was recorded and displayed on a computerized multichannel recording system (Bard EP). Electrophysiological tests including atrial, coronary sinus and ventricular pacing were performed for arrhythmia induction. If no arrhythmia was inducible, isoproterenol infusion was administered to increase baseline heart rate by more than 25% and electrophysiological tests were done again for arrhythmia induction. We could induce at least two echo beats in all patients with or without isoproterenol infusion before the ablation. </p></sec></sec><sec id="sec27142"><title>4. Results</title><p>There were 61 females and 33 males at the end of follow ups (mean age: 46 &#x000b1; 13;range 8 to 77). <xref ref-type="table" rid="tbl7291">Table 1</xref> shows the characteristics of patients in the two groups. No anesthesia complication, except transient oxygen desaturation, was seen during the procedure. Electrophysiological characteristics are summarized in <xref ref-type="table" rid="tbl7292">Table 2</xref>. After successful slow pathway ablation or modification, no more than one echo beat was induced in the patients with and without isoproterenol infusion up to three extra-stimuli from right atrium and coronary sinus. We could not induce arrhythmias from the right ventricle for patients in whom tacharrhymias were inducible from the right ventricular apex before ablation. Post ablation electrophysiological characteristics are summarized in <xref ref-type="table" rid="tbl7293">Table 3</xref>. All patients stayed in the hospital for rhythm and hemodynamic monitoring for 24 to 48 hours. The patients mean clinical follow up was 6 months (<xref ref-type="table" rid="tbl7293">Table 3</xref>). Fifty patients enrolled in each group to compare the effect of anesthesia on AVNRT induction and ablation but only 49 patients in the anesthetic group and 45 patients in the control group completed the entire follow up period. Only one clinical recurrence of tachyarrhythmias was suspected in each group (P value = 0.327). Before discharge, we asked patients about their satisfaction of the procedure. We asked them to give a score from very low to high (low, average, good and very good). In the anesthetic group patient satisfaction was significantly better than the other group (P value &#x0003c; 0.0001) (<xref ref-type="table" rid="tbl7294">Table 4</xref>). </p></sec><sec id="sec27143"><title>5. Discussion</title><p>This study demonstrated that intravenous anesthesia is a safe and effective procedure for patients undergoing slow pathway ablation. No significant sinus pause, sinus bradycardia or Atrioventricular (AV) block was seen during anesthesia. Lai et al. showed that intravenous propofol has no brady-arrhythmic effects (<xref rid="A10719R3" ref-type="bibr">3</xref>). <xref ref-type="table" rid="tbl7292">Table 2</xref> and <xref ref-type="table" rid="tbl7293">3</xref> demonstrate that, our anesthesia protocol has no effect on electrophysiological parameters. A few reports revealed that anesthetic agents have no significant clinical effects on sinoatrial node or Atrioventricular nodal (AVN) conductions (<xref rid="A10719R1" ref-type="bibr">1</xref>, <xref rid="A10719R3" ref-type="bibr">3</xref>, <xref rid="A10719R4" ref-type="bibr">4</xref>). There are some reports concerning the non-inducibility of AVNRT after intravenous sedation (<xref rid="A10719R5" ref-type="bibr">5</xref>), but these findings are restricted to pediatrics. We could induce at least two echo beats in all patients with documented supra ventricular tachyarrhythmia (SVT) compatible with AVNRT with or without anesthesia. Although anesthetic patients need more isoproterenol infusion for arrhythmia induction, but there was no significant difference between the two groups (<xref ref-type="table" rid="tbl7292">Table 2</xref>). To the best of our knowledge, patient&#x02019;s satisfaction after electrophysiological procedures was not checked in the previous articles (<xref rid="A10719R1" ref-type="bibr">1</xref>-<xref rid="A10719R5" ref-type="bibr">5</xref>). We suppose that the most important key is appropriate prematurity for arrhythmia induction. We used up to three extra-stimuli with minimum prematurity conducted from AV node with or without isoproterenol infusion in all patients for arrhythmia induction. All patients in the anesthetic group revealed their satisfaction after the procedure. On the basis of the current study, in adults, AVNRT induction is not related to anesthetic agents and it could be performed safely for all patients who undergo electrophysiological procedures for slow pathway ablation. Intravenous anesthesia increases patient&#x02019;s satisfaction without increasing complication rate or inducing disturbance in electrophysiological parameters.</p><table-wrap id="tbl7291" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Patients&#x02019; Characteristics with and without Anesthesia </title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th style="text-align: left;" rowspan="1" colspan="1"> With Anesthesia (n = 49) </th><th style="text-align: left;" rowspan="1" colspan="1"> Without Anesthesia (n = 42) </th><th style="text-align: left;" rowspan="1" colspan="1"> P value </th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Gender, female</bold>
</td><td rowspan="1" colspan="1"> 29 (59.2) </td><td rowspan="1" colspan="1"> 30 (71.4) <sup><xref ref-type="table-fn" rid="fn5036">b</xref></sup>
</td><td rowspan="1" colspan="1"> 0.223 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Age, y</bold>
</td><td rowspan="1" colspan="1"> 47.24 &#x000b1; 14.33 </td><td rowspan="1" colspan="1"> 46.12 &#x000b1; 12.37 <sup><xref ref-type="table-fn" rid="fn5037">c</xref></sup>
</td><td rowspan="1" colspan="1"> 0.692 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Weight</bold>
</td><td rowspan="1" colspan="1"> 75.16 &#x000b1; 14.56 </td><td rowspan="1" colspan="1"> 75.48 &#x000b1; 14.74 </td><td rowspan="1" colspan="1"> 0.919 </td></tr><tr><td rowspan="1" colspan="1">
<bold>LVEF</bold>
<sup><xref ref-type="table-fn" rid="fn5035">a</xref></sup>
</td><td rowspan="1" colspan="1"> 54.49 &#x000b1; 3.98 </td><td rowspan="1" colspan="1"> 52.74 &#x000b1; 8.42 </td><td rowspan="1" colspan="1"> 0.198 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Known case of CAD</bold>
</td><td rowspan="1" colspan="1"> 2 (4.2) </td><td rowspan="1" colspan="1"> 1 (2.4) </td><td rowspan="1" colspan="1"> &#x0003e; 0.99 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Known case of HTN</bold>
</td><td rowspan="1" colspan="1"> 7 (14.3) </td><td rowspan="1" colspan="1"> 6 (14.3) </td><td rowspan="1" colspan="1"> &#x0003e; 0.99 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Known case of DM</bold>
</td><td rowspan="1" colspan="1"> 6 (12.2) </td><td rowspan="1" colspan="1"> 3 (7.1) </td><td rowspan="1" colspan="1"> 0.498 </td></tr></tbody></table><table-wrap-foot><fn id="fn5035"><p><sup>a</sup> Abbreviations: CAD, coronary artery disease; DM, diabetes; HTN, hypertension; LVEF, left ventricular ejection fraction</p></fn><fn id="fn5036"><p><sup>b</sup> The data are shown with No. (%)</p></fn><fn id="fn5037"><p><sup>c</sup> The data are shown with Mean &#x000b1; SD</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl7292" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Pre-ablation Electrophysiological Characteristics of Patients with and without Anesthesia </title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th style="text-align: left;" rowspan="1" colspan="1"> With Anesthesia (n = 49) </th><th style="text-align: left;" rowspan="1" colspan="1"> Without Anesthesia (n = 42) </th><th style="text-align: left;" rowspan="1" colspan="1"> P value </th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>SCL </bold>
<sup><xref ref-type="table-fn" rid="fn5038">a</xref></sup>
</td><td rowspan="1" colspan="1"> 763.23 &#x000b1; 137.33 <sup><xref ref-type="table-fn" rid="fn5039">b</xref></sup>
</td><td rowspan="1" colspan="1"> 730.12 &#x000b1; 135.39 </td><td rowspan="1" colspan="1"> 0.259 </td></tr><tr><td rowspan="1" colspan="1">
<bold>PR interval </bold>
<sup><xref ref-type="table-fn" rid="fn5041">d</xref></sup>
</td><td rowspan="1" colspan="1"> 135.19 &#x000b1; 31.26 </td><td rowspan="1" colspan="1"> 135.33 &#x000b1; 24.26 </td><td rowspan="1" colspan="1"> 0.981 </td></tr><tr><td rowspan="1" colspan="1">
<bold>QRS duration</bold>
</td><td rowspan="1" colspan="1"> 97.77 &#x000b1; 50.79 </td><td rowspan="1" colspan="1"> 91.17 &#x000b1; 26.65 </td><td rowspan="1" colspan="1"> 0.453 </td></tr><tr><td rowspan="1" colspan="1">
<bold>QT interval</bold>
</td><td rowspan="1" colspan="1"> 396.09 &#x000b1; 51.46 </td><td rowspan="1" colspan="1"> 385.14 &#x000b1; 45.26 </td><td rowspan="1" colspan="1"> 0.292 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Sinus AH interval</bold>
</td><td rowspan="1" colspan="1"> 81.28 &#x000b1; 20.87 </td><td rowspan="1" colspan="1"> 86.00 &#x000b1; 25.46 </td><td rowspan="1" colspan="1"> 0.359 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Sinus HV interval</bold>
</td><td rowspan="1" colspan="1"> 50.33 &#x000b1; 7.06 </td><td rowspan="1" colspan="1"> 51.36 &#x000b1; 11.05 </td><td rowspan="1" colspan="1"> 0.620 </td></tr><tr><td rowspan="1" colspan="1">
<bold>AVWP</bold>
</td><td rowspan="1" colspan="1"> 331.38 &#x000b1; 56.86 </td><td rowspan="1" colspan="1"> 315.00 &#x000b1; 33.60 </td><td rowspan="1" colspan="1"> 0.132 </td></tr><tr><td rowspan="1" colspan="1">
<bold>VAWP</bold>
</td><td rowspan="1" colspan="1"> 323.07 &#x000b1; 63.77 </td><td rowspan="1" colspan="1"> 333.98 &#x000b1; 72.29 </td><td rowspan="1" colspan="1"> 0.462 </td></tr><tr><td rowspan="1" colspan="1">
<bold>AERP-FP</bold>
</td><td rowspan="1" colspan="1"> 333.64 &#x000b1; 76.56 </td><td rowspan="1" colspan="1"> 299.19 &#x000b1; 80.80 </td><td rowspan="1" colspan="1"> 0.159 </td></tr><tr><td rowspan="1" colspan="1">
<bold>AERP-AVN</bold>
</td><td rowspan="1" colspan="1"> 254.48 &#x000b1; 64.80 </td><td rowspan="1" colspan="1"> 253.64 &#x000b1; 59.29 </td><td rowspan="1" colspan="1"> 0.953 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Arrhythmia CL</bold>
</td><td rowspan="1" colspan="1"> 340.14 &#x000b1; 54.70 </td><td rowspan="1" colspan="1"> 346.97 &#x000b1; 55.23 </td><td rowspan="1" colspan="1"> 0.592 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Arrhythmia VA (HRA)</bold>
</td><td rowspan="1" colspan="1"> 67.53 &#x000b1; 38.84 </td><td rowspan="1" colspan="1"> 53.200 &#x000b1; 20.80 </td><td rowspan="1" colspan="1"> 0.054 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Pre-ablation Antegrade Jump</bold>
</td><td rowspan="1" colspan="1"> 22 (53.7) <sup><xref ref-type="table-fn" rid="fn5040">c</xref></sup>
</td><td rowspan="1" colspan="1"> 17 (37.8) </td><td rowspan="1" colspan="1"> 0.139 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Pre-ablation Retrograde Jump</bold>
</td><td rowspan="1" colspan="1"> 2 (5.1) </td><td rowspan="1" colspan="1"> 2 (4.4) </td><td rowspan="1" colspan="1"> 0.883 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Pre-ablation Isoproterenol Usege</bold>
</td><td rowspan="1" colspan="1"> 9(22.5) </td><td rowspan="1" colspan="1"> 7 (15.2) </td><td rowspan="1" colspan="1"> 0.387 </td></tr></tbody></table><table-wrap-foot><fn id="fn5038"><p><sup>a</sup> Abbreviations: AERP-FP, antegrade effective refractory period of fast pathway; AERP-AVN, antegrade effective refractory period of AV node; AVWP, atrio-ventricular wenckebach point; SCL, sinus cycle length; VAWP, ventriculo-atrial wenckebach point </p></fn><fn id="fn5039"><p><sup>b</sup> The data are shown with Mean &#x000b1; SD</p></fn><fn id="fn5040"><p><sup>c</sup> The data are shown with No. (%)</p></fn><fn id="fn5041"><p><sup>d</sup> All times are in millisecond</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl7293" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Post-ablation Electrophysiological Characteristics of Patients with and without Anesthesia </title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"> &#x000a0; </th><th style="text-align: left;" rowspan="1" colspan="1"> With Anesthesia <sup><xref ref-type="table-fn" rid="fn5042">a</xref></sup> (n = 49) </th><th style="text-align: left;" rowspan="1" colspan="1"> without Anesthesia (n = 42) </th><th style="text-align: left;" rowspan="1" colspan="1"> P value </th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>SCL</bold>
</td><td rowspan="1" colspan="1"> 693.28 &#x000b1; 211.65 </td><td rowspan="1" colspan="1"> 648.17 &#x000b1; 123.56 </td><td rowspan="1" colspan="1"> 0.310 </td></tr><tr><td rowspan="1" colspan="1">
<bold>AH interval</bold>
</td><td rowspan="1" colspan="1"> 105.25 &#x000b1; 127.25 </td><td rowspan="1" colspan="1"> 77.24 &#x000b1; 18.95 </td><td rowspan="1" colspan="1"> 0.245 </td></tr><tr><td rowspan="1" colspan="1">
<bold>HV interval</bold>
</td><td rowspan="1" colspan="1"> 52.05 &#x000b1; 12.98 </td><td rowspan="1" colspan="1"> 51.31 &#x000b1; 10.25 </td><td rowspan="1" colspan="1"> 0.803 </td></tr><tr><td rowspan="1" colspan="1">
<bold>AVWP</bold>
</td><td rowspan="1" colspan="1"> 396.28 &#x000b1; 43.93 </td><td rowspan="1" colspan="1"> 315.70 &#x000b1; 43.90 </td><td rowspan="1" colspan="1"> 0.265 </td></tr><tr><td rowspan="1" colspan="1">
<bold>AERP-FP</bold>
</td><td rowspan="1" colspan="1"> 304.44 &#x000b1; 45.85 </td><td rowspan="1" colspan="1"> 290.00 &#x000b1; 28.86 </td><td rowspan="1" colspan="1"> 0.480 </td></tr><tr><td rowspan="1" colspan="1">
<bold>AERP-AVN</bold>
</td><td rowspan="1" colspan="1"> 274.75 &#x000b1; 57.92 </td><td rowspan="1" colspan="1"> 268.96 &#x000b1; 43.37 </td><td rowspan="1" colspan="1"> 0.655 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Slow pathway ablation, No. (%)</bold>
</td><td rowspan="1" colspan="1"> 25 (25.2) </td><td rowspan="1" colspan="1"> 25 (61.0) </td><td rowspan="1" colspan="1"> 0.399 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Procedure time</bold>
</td><td rowspan="1" colspan="1"> 26.43 &#x000b1; 22.50 </td><td rowspan="1" colspan="1"> 32.15 &#x000b1; 51.34 </td><td rowspan="1" colspan="1"> 0.504 </td></tr><tr><td rowspan="1" colspan="1">
<bold>Duration of Follow Up</bold>
</td><td rowspan="1" colspan="1"> 6.17 &#x000b1; 3.31 </td><td rowspan="1" colspan="1"> 6.39 &#x000b1; 3.62 </td><td rowspan="1" colspan="1"> 0.777 </td></tr></tbody></table><table-wrap-foot><fn id="fn5042"><p><sup>a</sup> All the data are shown with Mean &#x000b1; SD</p></fn></table-wrap-foot></table-wrap><p>Procedure time is in minutes, Duration of follow up is in months and other times are in millisecond. We analyzed slow pathway ablation vs. modification after AVNRT termination.</p><table-wrap id="tbl7294" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Patient Satisfaction after AVNRT Ablation </title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"> &#x000a0; </th><th style="text-align: left;" rowspan="1" colspan="1"> Very Low (n = 7) </th><th style="text-align: left;" rowspan="1" colspan="1"> Low (n = 28) </th><th style="text-align: left;" rowspan="1" colspan="1"> Intermediate (n = 7) </th><th style="text-align: left;" rowspan="1" colspan="1"> High (n = 37) </th><th style="text-align: left;" rowspan="1" colspan="1"> P value </th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Patients without anesthesia, No. (%)</bold>
</td><td rowspan="1" colspan="1"> 7 (17.1) </td><td rowspan="1" colspan="1"> 27 (65.9) </td><td rowspan="1" colspan="1"> 6 (14.6) </td><td rowspan="1" colspan="1"> 1 (2.4) </td><td rowspan="1" colspan="1"> 0.0001 </td></tr><tr><td rowspan="1" colspan="1">
<bold>With Anesthesia, No. (%)</bold>
</td><td rowspan="1" colspan="1"> 0 (0.0) </td><td rowspan="1" colspan="1"> 1 (2.1) </td><td rowspan="1" colspan="1"> 1 (2.1) </td><td rowspan="1" colspan="1"> 36 (76.6) </td><td rowspan="1" colspan="1"> 0.0001 </td></tr></tbody></table></table-wrap></sec></body><back><ack><p>We thank the staff of the EP lab for assisting with the data collection and also cardiac electrophysiology support for assisting this project.</p></ack><fn-group><fn id="afn16517" fn-type="other"><p><bold>Implication for health policy/practice/research/medical education:</bold>Sedation during AVNRT ablation can increase patient's satisfaction.</p></fn><fn id="afn16518" fn-type="other"><p><bold>Authors&#x02019; Contribution:</bold>Amir Farjam Fazelifar: conducted the manuscript, case section, clinical study; Ali Eskandari: reviewed the literature and clinical study, Mohammad Jafar Hashemi: clinical study and case selection; Mostafa Alavi: management and clinical study; Mohammadzia Totounchi: management and clinical study of the outpatient; Azam Forghanian: data collection; Mahboubeh Zeighami: data collection, Zahra Emkanjoo: clinical study; Majid Haghjoo, clinical study. We thank all the staff of the EP lab for assisting with the data collection and also cardiac electrophysiology support for assisting with this project.</p></fn><fn id="afn16519" fn-type="financial-disclosure"><p><bold>Financial Disclosure:</bold>There is not any conflict of interest.</p></fn><fn id="afn16520" fn-type="supported-by"><p><bold>Funding Support:</bold>This Project has been supported financially by the Cardiac Electrophysiology Research center, Iran University of Medical Sciences.</p></fn></fn-group><ref-list><title>References</title><ref id="A10719R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavoie</surname><given-names>J</given-names></name><name><surname>Walsh</surname><given-names>EP</given-names></name><name><surname>Burrows</surname><given-names>FA</given-names></name><name><surname>Laussen</surname><given-names>P</given-names></name><name><surname>Lulu</surname><given-names>JA</given-names></name><name><surname>Hansen</surname><given-names>DD</given-names></name></person-group><article-title>Effects of propofol or isoflurane anesthesia on cardiac conduction in children undergoing radiofrequency catheter ablation for tachydysrhythmias.</article-title><source>Anesthesiology.</source><year>1995</year><volume>82</volume><issue>4</issue><fpage>884</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7717559</pub-id></element-citation></ref><ref id="A10719R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>LA</given-names></name><name><surname>Huang</surname><given-names>SK</given-names></name><name><surname>Wagshal</surname><given-names>AB</given-names></name><name><surname>Kulkarni</surname><given-names>RS</given-names></name></person-group><article-title>Electrophysiological effects of propofol on the normal cardiac conduction system.</article-title><source>Cardiology.</source><year>1996</year><volume>87</volume><issue>4</issue><fpage>319</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8793167</pub-id></element-citation></ref><ref id="A10719R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>LP</given-names></name><name><surname>Lin</surname><given-names>JL</given-names></name><name><surname>Wu</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>CH</given-names></name><name><surname>Yeh</surname><given-names>HM</given-names></name><etal>et al.</etal></person-group><article-title>Usefulness of intravenous propofol anesthesia for radiofrequency catheter ablation in patients with tachyarrhythmias: infeasibility for pediatric patients with ectopic atrial tachycardia.</article-title><source>Pacing Clin Electrophysiol.</source><year>1999</year><volume>22</volume><issue>9</issue><fpage>1358</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">10527017</pub-id></element-citation></ref><ref id="A10719R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharpe</surname><given-names>MD</given-names></name><name><surname>Dobkowski</surname><given-names>WB</given-names></name><name><surname>Murkin</surname><given-names>JM</given-names></name><name><surname>Klein</surname><given-names>G</given-names></name><name><surname>Yee</surname><given-names>R</given-names></name></person-group><article-title>Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.</article-title><source>Anesthesiology.</source><year>1995</year><volume>82</volume><issue>4</issue><fpage>888</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">7717560</pub-id></element-citation></ref><ref id="A10719R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmel</surname><given-names>M</given-names></name><name><surname>Brockmeier</surname><given-names>K</given-names></name><name><surname>Sreeram</surname><given-names>N</given-names></name></person-group><article-title>Slow pathway ablation in children with documented reentrant supraventricular tachycardia not inducible during invasive electrophysiologic study.</article-title><source>Z Kardiol.</source><year>2005</year><volume>94</volume><issue>12</issue><fpage>808</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s00392-005-0305-3</pub-id><pub-id pub-id-type="pmid">16382381</pub-id></element-citation></ref></ref-list></back></article>